These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 23019264)
21. Predictors and outcomes of fluctuations in the clinical dementia rating scale. Wilks H; Benzinger TLS; Schindler SE; Cruchaga C; Morris JC; Hassenstab J Alzheimers Dement; 2024 Mar; 20(3):2080-2088. PubMed ID: 38224146 [TBL] [Abstract][Full Text] [Related]
22. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study. Pedersen KF; Larsen JP; Tysnes OB; Alves G Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638 [TBL] [Abstract][Full Text] [Related]
23. Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal. Vermunt L; van Paasen AJL; Teunissen CE; Scheltens P; Visser PJ; Tijms BM; Neurology; 2019 Jun; 92(23):e2699-e2705. PubMed ID: 31068481 [TBL] [Abstract][Full Text] [Related]
24. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Roberts RO; Knopman DS; Mielke MM; Cha RH; Pankratz VS; Christianson TJ; Geda YE; Boeve BF; Ivnik RJ; Tangalos EG; Rocca WA; Petersen RC Neurology; 2014 Jan; 82(4):317-25. PubMed ID: 24353333 [TBL] [Abstract][Full Text] [Related]
25. Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis. Saredakis D; Collins-Praino LE; Gutteridge DS; Stephan BCM; Keage HAD Parkinsonism Relat Disord; 2019 Aug; 65():20-31. PubMed ID: 31109727 [TBL] [Abstract][Full Text] [Related]
26. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study. Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117 [TBL] [Abstract][Full Text] [Related]
27. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid. Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990 [TBL] [Abstract][Full Text] [Related]
28. Mild cognitive impairment and dementia in primary care: the value of medical history. Olazarán J; Torrero P; Cruz I; Aparicio E; Sanz A; Mula N; Marzana G; Cabezón D; Begué C Fam Pract; 2011 Aug; 28(4):385-92. PubMed ID: 21402661 [TBL] [Abstract][Full Text] [Related]
29. The Informant Questionnaire on Cognitive Decline in the Elderly individuals in screening mild cognitive impairment with or without functional impairment. Li F; Jia XF; Jia J J Geriatr Psychiatry Neurol; 2012 Dec; 25(4):227-32. PubMed ID: 23172761 [TBL] [Abstract][Full Text] [Related]
31. Factors for predicting reversion from mild cognitive impairment to normal cognition: A meta-analysis. Xue H; Hou P; Li Y; Mao X; Wu L; Liu Y Int J Geriatr Psychiatry; 2019 Oct; 34(10):1361-1368. PubMed ID: 31179580 [TBL] [Abstract][Full Text] [Related]
32. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease. Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836 [TBL] [Abstract][Full Text] [Related]
33. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Morris JC Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163 [TBL] [Abstract][Full Text] [Related]
34. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates. Duara R; Loewenstein DA; Greig MT; Potter E; Barker W; Raj A; Schinka J; Borenstein A; Schoenberg M; Wu Y; Banko J; Potter H Am J Geriatr Psychiatry; 2011 Nov; 19(11):951-60. PubMed ID: 21422909 [TBL] [Abstract][Full Text] [Related]
35. Personality and Transition From Mild Cognitive Impairment to Normal Cognition vs Dementia. Stephan Y; Sutin AR; Luchetti M; Aschwanden D; Terracciano A J Am Med Dir Assoc; 2024 Oct; 25(10):105175. PubMed ID: 39074784 [TBL] [Abstract][Full Text] [Related]
36. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593 [TBL] [Abstract][Full Text] [Related]
37. Association of Seizure Control With Cognition in People With Normal Cognition and Mild Cognitive Impairment. Zawar I; Kapur J; Mattos MK; Aldridge CM; Manning C; Quigg M Neurology; 2024 Sep; 103(6):e209820. PubMed ID: 39173101 [TBL] [Abstract][Full Text] [Related]
38. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism. Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A; J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655 [TBL] [Abstract][Full Text] [Related]
39. Study of the Risk and Preventive Factors for Progress of Mild Cognitive Impairment to Dementia. Hu C; Wang L; Guo Y; Cao Z; Lu Y; Qin H Am J Alzheimers Dis Other Demen; 2020; 35():1533317520925324. PubMed ID: 32567328 [TBL] [Abstract][Full Text] [Related]
40. Frequency and course of mild cognitive impairment in a multiethnic community. Manly JJ; Tang MX; Schupf N; Stern Y; Vonsattel JP; Mayeux R Ann Neurol; 2008 Apr; 63(4):494-506. PubMed ID: 18300306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]